We are live on ! Find out more
LPL Financial

LPL Financial Portfolio holdings

AUM $445B
1-Year Est. Return 25.58%
 

LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+25.58%
3 Year Est. Return
+70.01%
5 Year Est. Return
+71.01%
10 Year Est. Return
+238.03%
AUM
$366B
AUM Growth
+$23.1B
Cap. Flow
+$17.7B
Cap. Flow %
4.83%
Top 10 Hldgs %
15.17%
Holding
6,133
New
355
Increased
3,269
Reduced
2,125
Closed
267

Sector Composition

Rank Sector Weight
1 Technology 8.6%
2 Financials 3.6%
3 Consumer Discretionary 2.68%
4 Communication Services 2.56%
5 Healthcare 2.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PROP icon
5776
Prairie Operating Co
PROP
$78.1M
$25.6K ﹤0.01%
15,168
-40,731
-73% -$74K
CISO
5777
CISO Global
CISO
$12.1M
$25.5K ﹤0.01%
53,010
-2,917
-5% -$2.39K
CRBU icon
5778
Caribou Biosciences
CRBU
$164M
$24.7K ﹤0.01%
15,524
+5,228
+51% +$11K
GPMT
5779
Granite Point Mortgage Trust
GPMT
$61.2M
$24.6K ﹤0.01%
+10,258
New +$27.5K
FATE icon
5780
CALL
Fate Therapeutics
FATE
$326M
$24.6K ﹤0.01%
+25,000
New +$30K
HUMAW icon
5781
Humacyte Inc Warrant
HUMAW
$1.24M
$24.3K ﹤0.01%
259,115
CNDT icon
5782
Conduent
CNDT
$264M
$24.1K ﹤0.01%
12,532
-11,953
-49% -$26.2K
DCGO icon
5783
DocGo
DCGO
$62.6M
$23.7K ﹤0.01%
+27,000
New +$28.8K
ATYR
5784
aTyr Pharma
ATYR
$50.1M
$23.6K ﹤0.01%
+30,100
New +$24.7K
GUTS icon
5785
Fractyl Health
GUTS
$111M
$22.9K ﹤0.01%
10,425
AGIG
5786
Abundia Global Impact Group
AGIG
$36.5M
$22.5K ﹤0.01%
11,370
-10,976
-49% -$44.1K
TCRX icon
5787
TScan Therapeutics
TCRX
$52M
$22.5K ﹤0.01%
22,500
+1,000
+5% +$1.45K
APRE icon
5788
Aprea Therapeutics
APRE
$8.05M
$22.2K ﹤0.01%
26,052
+10,000
+62% +$12.3K
SLNH icon
5789
Soluna Holdings
SLNH
$185M
$21.6K ﹤0.01%
18,427
-2,351
-11% -$5.36K
CRIS icon
5790
Curis
CRIS
$7.83M
$21.3K ﹤0.01%
1,079
OPENZ
5791
Opendoor Technologies Inc Series Z Warrants
OPENZ
$4.14M
$20.6K ﹤0.01%
+51,666
New +$31.3K
ARBE icon
5792
Arbe Robotics
ARBE
$94.2M
$20.4K ﹤0.01%
17,300
-2,000
-10% -$3.3K
INVZ icon
5793
Innoviz Technologies
INVZ
$112M
$19.9K ﹤0.01%
23,292
+5,740
+33% +$9.09K
LFWD icon
5794
ReWalk Robotics
LFWD
$21.6M
$19.7K ﹤0.01%
2,853
+663
+30% +$5.16K
CTXR icon
5795
Citius Pharmaceuticals
CTXR
$18.7M
$19.5K ﹤0.01%
+25,067
New +$31.3K
OCGN icon
5796
Ocugen
OCGN
$434M
$19.1K ﹤0.01%
+14,120
New +$20.1K
COCH icon
5797
Envoy Medical
COCH
$51.7M
$18.8K ﹤0.01%
28,401
PLX icon
5798
Protalix BioTherapeutics
PLX
$198M
$18.5K ﹤0.01%
10,291
MGX icon
5799
Metagenomi Therapeutics
MGX
$46.3M
$18.3K ﹤0.01%
+11,297
New +$24.5K
BRN icon
5800
Barnwell Industries
BRN
$14.1M
$17.8K ﹤0.01%
16,000
-198
-1% -$235

Similar funds

LPL Financial's Q4 2025 Portfolio in Review

As of Q4 2025, LPL Financial held 6,133 positions worth $366B, up 6.7% from $343B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

LPL Financial deployed $17.7B of net new capital in Q4 2025, opening 355 new positions and adding to 3,269 existing holdings. Its largest new stake was Akre Focus ETF: 2,308,689 shares worth $151M.

By sector, the portfolio is most concentrated in Technology at 8.6% of assets, down from 8.8% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares MSCI USA Quality Factor ETF, an estimated $461M trimmed.

  • LPL Financial's largest Q4 2025 buy was Akre Focus ETF: 2,308,689 shares worth $151M.
  • LPL Financial added most to iShares S&P 500 Value ETF in Q4 2025, an estimated $517M increase.
  • LPL Financial's biggest Q4 2025 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $461M.
  • LPL Financial fully exited Invesco BulletShares 2025 Corporate Bond ETF in Q4 2025, selling an estimated $119M.
  • LPL Financial's ten largest holdings make up 15% of its $366B portfolio in Q4 2025.
  • LPL Financial opened 355 new positions and closed 267 in Q4 2025.
  • LPL Financial's portfolio value rose 6.7% quarter-over-quarter to $366B.

Based on LPL Financial's 13F filing for Q4 2025, filed 11 Feb 2026.